Procurement Summary
Country: Kazakhstan
Summary: Purchase Antibotulinum Serum, Amt: 2425000.00
Deadline: 16 Jun 2026
Posting Date: 13 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143238574
Document Ref. No.: 17173756-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 2425000.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Lots: Anti-botulinum serum type B horse purified concentrated liquid 10000 IU No. 5 • Active ingredient: Highly purified specific immunoglobulins obtained from the blood serum of hyperimmunized horses. • Release form: Liquid solution for injection, packaged in ampoules. • Dosage: Contains at least 2500 IU (international units) of antitoxin per ml. The therapeutic dose of the drug is at least 10, 000 IU. • Types: Available as monovalent (versus types A, B or E) and polyvalent serums. • Appearance: Transparent or slightly opalescent yellowish liquid. | Equine anti-botulinum serum type E purified concentrated liquid 10000 IU No. 5 • Active ingredient: Highly purified specific immunoglobulins obtained from the blood serum of hyperimmunized horses. • Release form: Liquid solution for injection, packaged in ampoules. • Dosage: Contains at least 2500 IU (international units) of antitoxin per ml. Therapeutic dose of the drug is at least 10, 000 IU. • Types: Available as monovalent (against types A, B or E) and polyvalent serums. • Appearance: Transparent or slightly opalescent yellowish liquid. | Serum against the venom of the karakurt horse spider purified conc. liquid 250 EA 2.5 Composition: A solution of specific antibodies obtained from the blood plasma of horses hyperimmunized with karakurt poison. • Release form: Liquid, poured into ampoules (usually from 2.5 ml to 5...
Documents
Tender Notice